Vaccination vs Monoclonal Antibodies in Preventing Risk of Severe COVID-19 Illness

Authors

Nicole Corazon, Baptist Hospital of MiamiFollow
Tabitha Hernandez, Baptist Hospital of MiamiFollow
Melissa Tellechea, Baptist Hospital of MiamiFollow
Valerie Marcia, Baptist Hospital of MiamiFollow
Sadaf Salim, Baptist Hospital of MiamiFollow
Melissa Diaz Bernal, Baptist Hospital of MiamiFollow
Ashley Garcia, Baptist Hospital of MiamiFollow
Jonathan Marquez, Baptist Hospital of MiamiFollow
Maydel Fernandez Quevedo, Baptist Hospital of MiamiFollow
Kristen Crooks, Baptist Hospital of MiamiFollow
Precilla Bernard, Baptist Hospital of MiamiFollow
Tadaaki Horigome, Baptist Hospital of MiamiFollow
Bernadette Bedgood, Baptist Hospital of MiamiFollow
Stephani Cardona, Baptist Hospital of MiamiFollow
Marelyn Sequeira, Baptist Hospital of MiamiFollow
Yitsi Perdomo, Baptist Hospital of MiamiFollow

Files

Publication Date

11-19-2021

Document Type

Video - BHSF/IP Restricted Access

Recommended Citation

Corazon, Nicole; Hernandez, Tabitha; Tellechea, Melissa; Marcia, Valerie; Salim, Sadaf; Diaz Bernal, Melissa; Garcia, Ashley; Marquez, Jonathan; Fernandez Quevedo, Maydel; Crooks, Kristen; Bernard, Precilla; Horigome, Tadaaki; Bedgood, Bernadette; Cardona, Stephani; Sequeira, Marelyn; and Perdomo, Yitsi, "Vaccination vs Monoclonal Antibodies in Preventing Risk of Severe COVID-19 Illness" (2021). BHSF Cohort 6 EBP Showcase. 19.
https://scholarlycommons.baptisthealth.net/cohort-6-ebp-showcase/19